annual EBITDA:
-$101.74M-$42.95M(-73.06%)Summary
- As of today (September 16, 2025), WVE annual EBITDA is -$101.74 million, with the most recent change of -$42.95 million (-73.06%) on December 31, 2024.
- During the last 3 years, WVE annual EBITDA has risen by +$15.44 million (+13.18%).
- WVE annual EBITDA is now -2984.90% below its all-time high of -$3.30 million, reached on December 31, 2013.
Performance
WVE EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$50.56M-$2.92M(-6.14%)Summary
- As of today (September 16, 2025), WVE quarterly EBITDA is -$50.56 million, with the most recent change of -$2.92 million (-6.14%) on June 30, 2025.
- Over the past year, WVE quarterly EBITDA has dropped by -$17.74 million (-54.04%).
- WVE quarterly EBITDA is now -301.26% below its all-time high of $25.12 million, reached on December 31, 2024.
Performance
WVE quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$134.84M-$17.74M(-15.15%)Summary
- As of today (September 16, 2025), WVE TTM EBITDA is -$134.84 million, with the most recent change of -$17.74 million (-15.15%) on June 30, 2025.
- Over the past year, WVE TTM EBITDA has dropped by -$59.94 million (-80.03%).
- WVE TTM EBITDA is now -10575.93% below its all-time high of -$1.26 million, reached on September 30, 2014.
Performance
WVE TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
WVE EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -73.1% | -54.0% | -80.0% |
3 y3 years | +13.2% | -27.5% | -18.3% |
5 y5 years | +48.9% | -39.8% | +29.1% |
WVE EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -73.1% | +33.3% | -301.3% | +18.1% | -129.3% | +11.6% |
5 y | 5-year | -73.1% | +48.9% | -301.3% | +18.1% | -129.3% | +29.1% |
alltime | all time | -2984.9% | +48.9% | -301.3% | +18.1% | <-9999.0% | +32.3% |
WVE EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | -$50.56M(+6.1%) | -$134.84M(+15.1%) |
Mar 2025 | - | -$47.64M(-289.6%) | -$117.10M(+15.1%) |
Dec 2024 | -$101.74M(+73.1%) | $25.12M(-140.7%) | -$101.74M(-29.0%) |
Sep 2024 | - | -$61.76M(+88.1%) | -$143.36M(+91.4%) |
Jun 2024 | - | -$32.83M(+1.7%) | -$74.90M(+18.5%) |
Mar 2024 | - | -$32.28M(+95.6%) | -$63.22M(+7.5%) |
Dec 2023 | -$58.79M(-61.5%) | -$16.50M(-346.0%) | -$58.79M(-29.5%) |
Sep 2023 | - | $6.71M(-131.7%) | -$83.36M(-34.0%) |
Jun 2023 | - | -$21.15M(-24.0%) | -$126.36M(-12.8%) |
Mar 2023 | - | -$27.85M(-32.2%) | -$144.87M(-5.1%) |
Dec 2022 | -$152.61M(+30.2%) | -$41.07M(+13.1%) | -$152.61M(+5.2%) |
Sep 2022 | - | -$36.30M(-8.5%) | -$145.11M(+27.3%) |
Jun 2022 | - | -$39.66M(+11.5%) | -$114.02M(+2.0%) |
Mar 2022 | - | -$35.58M(+6.0%) | -$111.75M(-4.6%) |
Dec 2021 | -$117.18M(-18.3%) | -$33.57M(+544.4%) | -$117.18M(+5.2%) |
Sep 2021 | - | -$5.21M(-86.1%) | -$111.41M(-19.3%) |
Jun 2021 | - | -$37.39M(-8.8%) | -$138.11M(+0.9%) |
Mar 2021 | - | -$41.01M(+47.5%) | -$136.89M(-2.2%) |
Dec 2020 | -$143.39M(-28.0%) | -$27.80M(-12.9%) | -$139.99M(-17.8%) |
Sep 2020 | - | -$31.91M(-11.8%) | -$170.29M(-10.5%) |
Jun 2020 | - | -$36.17M(-18.0%) | -$190.21M(-3.6%) |
Mar 2020 | - | -$44.11M(-24.1%) | -$197.40M(-0.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2019 | -$199.12M(+29.3%) | -$58.10M(+12.1%) | -$199.12M(+5.8%) |
Sep 2019 | - | -$51.82M(+19.5%) | -$188.24M(+8.7%) |
Jun 2019 | - | -$43.37M(-5.4%) | -$173.19M(+4.9%) |
Mar 2019 | - | -$45.82M(-3.0%) | -$165.17M(+7.3%) |
Dec 2018 | -$153.94M(+53.6%) | -$47.23M(+28.4%) | -$153.94M(+12.4%) |
Sep 2018 | - | -$36.77M(+4.1%) | -$136.98M(+8.7%) |
Jun 2018 | - | -$35.34M(+2.1%) | -$125.97M(+9.6%) |
Mar 2018 | - | -$34.60M(+14.3%) | -$114.94M(+14.7%) |
Dec 2017 | -$100.24M(+82.5%) | -$30.27M(+17.5%) | -$100.24M(+13.6%) |
Sep 2017 | - | -$25.76M(+5.9%) | -$88.21M(+11.0%) |
Jun 2017 | - | -$24.32M(+22.2%) | -$79.50M(+19.3%) |
Mar 2017 | - | -$19.89M(+9.0%) | -$66.64M(+22.2%) |
Dec 2016 | -$54.94M(+193.7%) | -$18.25M(+7.0%) | -$54.54M(+25.7%) |
Sep 2016 | - | -$17.05M(+48.8%) | -$43.38M(+39.8%) |
Jun 2016 | - | -$11.45M(+46.9%) | -$31.04M(+34.2%) |
Mar 2016 | - | -$7.80M(+10.1%) | -$23.13M(+23.6%) |
Dec 2015 | -$18.70M(+265.8%) | -$7.08M(+50.5%) | -$18.70M(+40.5%) |
Sep 2015 | - | -$4.71M(+32.9%) | -$13.32M(+34.9%) |
Jun 2015 | - | -$3.54M(+4.9%) | -$9.87M(+55.9%) |
Mar 2015 | - | -$3.38M(+99.3%) | -$6.33M(+114.2%) |
Dec 2014 | -$5.11M(+55.0%) | -$1.69M(+34.1%) | -$2.96M(+134.1%) |
Sep 2014 | - | -$1.26M | -$1.26M |
Dec 2013 | -$3.30M | - | - |
FAQ
- What is Wave Life Sciences Ltd. annual EBITDA?
- What is the all time high annual EBITDA for Wave Life Sciences Ltd.?
- What is Wave Life Sciences Ltd. annual EBITDA year-on-year change?
- What is Wave Life Sciences Ltd. quarterly EBITDA?
- What is the all time high quarterly EBITDA for Wave Life Sciences Ltd.?
- What is Wave Life Sciences Ltd. quarterly EBITDA year-on-year change?
- What is Wave Life Sciences Ltd. TTM EBITDA?
- What is the all time high TTM EBITDA for Wave Life Sciences Ltd.?
- What is Wave Life Sciences Ltd. TTM EBITDA year-on-year change?
What is Wave Life Sciences Ltd. annual EBITDA?
The current annual EBITDA of WVE is -$101.74M
What is the all time high annual EBITDA for Wave Life Sciences Ltd.?
Wave Life Sciences Ltd. all-time high annual EBITDA is -$3.30M
What is Wave Life Sciences Ltd. annual EBITDA year-on-year change?
Over the past year, WVE annual EBITDA has changed by -$42.95M (-73.06%)
What is Wave Life Sciences Ltd. quarterly EBITDA?
The current quarterly EBITDA of WVE is -$50.56M
What is the all time high quarterly EBITDA for Wave Life Sciences Ltd.?
Wave Life Sciences Ltd. all-time high quarterly EBITDA is $25.12M
What is Wave Life Sciences Ltd. quarterly EBITDA year-on-year change?
Over the past year, WVE quarterly EBITDA has changed by -$17.74M (-54.04%)
What is Wave Life Sciences Ltd. TTM EBITDA?
The current TTM EBITDA of WVE is -$134.84M
What is the all time high TTM EBITDA for Wave Life Sciences Ltd.?
Wave Life Sciences Ltd. all-time high TTM EBITDA is -$1.26M
What is Wave Life Sciences Ltd. TTM EBITDA year-on-year change?
Over the past year, WVE TTM EBITDA has changed by -$59.94M (-80.03%)